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Abstract

Distance Correlation is another newer choice to compute the relation between
variables. However, the Bayesian counterpart of Distance Correlation is not established. In this paper, Bayesian counterpart of Distance Correlation is pro- posed.
Proposed method is illustrated with Liver Chirrhosis Marker data. The relevant
studies information about relation between AST and ALT is used to formulate the
prior information for Bayesian computation. The Distance Correlation between
AST and ALT (both are liver performance marker) is computed with 0.44. The
credible interval is observed with (0.41, 0.46).Bayesian counter- part to compute
Distance correlation is simple and handy.
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Abstract
Distance Correlation is another newer choice to compute the relation between
variables. However, the Bayesian counterpart of Distance Correlation is not
established. In this paper, Bayesian counterpart of Distance Correlation is proposed. Proposed method is illustrated with Liver Chirrhosis Marker data. The
relevant studies information about relation between AST and ALT is used to
formulate the prior information for Bayesian computation. The Distance Correlation between AST and ALT (both are liver performance marker) is computed
with 0.44. The credible interval is observed with (0.41, 0.46).Bayesian counterpart to compute Distance correlation coefficient is simple and handy.
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Introduction
The dependence between random vectors can be measured by distance correlation(DC). It is equally appropriate for equal and unequal dimensional measurement [1, 2]. The range of DC is [0, 1]. It provides platform to measure
with multivariate independence. It is a generalized form of Pearson correlation.It is found consistent for all dependent alternatives through finite second
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moments [3].The bias outcome of DC through different dimension also been
tested[3]. The unbiased t-test is found suitable to test the independence nature
for distance correlation.Pearson correlation and Spearman’s correlation are the
most explored measurement in medical research over the last century. Both are
widely explored tool to explore relation between variable. The DC is extended
for high dimensional data [4]. The application of distance correlation for functional data also been extended recently through Hilber space [5].However, the
limitation of DC to be applied for high dimension data also being elaborated[6].
Recently, several new tools are available to the scientific community for more
complex issue through Cannonical , Rank and Renyi correlation [4]. However,
all of them having some advantages and limitations[7]. The joint independences
of random variable can be explored through DC [2]. It is matrix inversion free.
Dependences measurement between two random variables can be observed and
tested through it [8]. In experimental study, relation between two variable of
interest plays always important role. Medical practice is based on known information about relation between two variables. Preventive and curative measures
of medical disciplines is stand on relative relation between variables.Particularly,
it is essential in experimental and medical research as tool to explore complex
relation between random variables. In this article, we first elaborate the DC.
Next, we discuss Bayesian approach in general and then Bayesian approach to
compute Distance Correlation. In this work the default Bayesian approach is
presented to compute the DC. The method is illustrated with clinical trial example. The intention of this work is to present some handy tool to the researcher
involved to explored the relation between variables.

Distance Covariance and Distance Correlation
Distance covariance between the random variables X and Y is defined with
marginal characteristic function of fY (t) andfY (s) by,
V 2 (X, Y ) = [f(X,Y ) (t, s) − fX (t)fY (s)]2

(1)

2
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The function f(X,Y ) is joint characteristics function of X and Y . The terms sand
t are the vectors and the product of t and s is < t, s > .The distance covariance
measures the distance ||f(X,Y ) (t, s) − f(X) f(Y ) (s)|| between the joint characteristic function and marginal characteristics function. The random vector X and
Y are in Rp and Rq respectively. The hypothesis is H0 : fX,Y = fX fY and
H1 : fX,Y ̸= fX fY The distance variance is
V (X) = [f(X,X (t, s) − fX (t)fX (s)]

(2)

DC between X and Y is defined with finite first moments R(X, Y ) by
V 2 (X, Y )
R2 (X, Y ) = √
>0
V 2 (X)V 2 (Y )

(3)

The distance covariance Vn (X, Y ) is defined with
Vn2 (X, Y ) =

n
1 ∑
Akl Bkl
n2

(4)

k,l=1

Similarly it can be defined as
Vn2 (X, X) =
The parameters are akl = |Xl − Yl |, āk. =
∑n
and ā.. = n12 k=1 akl ,

1
n

1
n2
∑n
k=1

A = akl − ā.l + ā..

(5)
akl , ā.l =

1
n

∑n
k=1

akl ,

(6)

Similarly, BkL is defined.

Properties
The DC provides the scope to generalize the correlation between variables
(X and Y ) by R. It is defined on arbitrary dimensions R = 0 for independent
of X and Y . The range of DC is 0 < R < 1.The R can be defined as the
function of Pearson correlation coefficient ρ with R(X, Y ) < |ρ(X, Y )| with
equality when ρ ± 1. The random variables X and Y are express as Ai = Xi + ϵi
and Bj = Yj + ϵj respectively. The error terms ϵi and ϵj are independent with
3
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the variables Xi and Yj . Let the relation between random functions Ai and Bj
is irrelevant. But the relation between Xi and Yj is importance and matter of
concerned. The strength of relation between X and Y can be measured through
DC in this scenario.

In One-sided Test
The frequency approach test the problem through p(X) value of the null
hypothesis H0 . In contrast, Bayesian measures through posterior probability
p(H0 |X). Let the data follows normal distribution (θ, σ 2 )with null hypothesis
H0 : θ ≤ 0 and H1 : θ > 0. The frequency and robust Bayesian often coincide [9].
Let the marginal DC ρ is applied between p(X) = 1−Φ(X/σ) and p(H0 |X).The
DC should be greater than or equal to zero. Because p(X) and p(H0 |X) both
are decreasing with respect to X.

Parameter and Unbiased Estimator
Suppose, (θ, X) are the random variables with joint characteristics function
f(X,Y ) (t, s) and marginal distribution of θ is π. The estimator of θ is δ(X) and
square error loss is r(π, δ) = E[δ(X) − θ]2 and risk is δπ (X) = E(θ/X). The
DC between θ and δ(X) is
var(θ) + cov{θ, b(θ)}
√
ρ(θ, δ(X)) = √
var(θ) var{θ + (θ)} + τ (π, δ) − E{b2 (θ)}

(7)

Method
The Bayes’ Theorem provides the prior information about the relevant parameter for the specific statistical analysis. It is helpful to test the hypothesis
in presence of posterior probability of the parameter of interest. The parameter
of interest R(X, Y ) can be computed with posterior probability through Bayes’
theorem
P (R(X, Y )/Inf ormation) =

P (Inf ormation/R(X, Y ))P (R(X, Y ))
P (Inf ormation)

(8)

4
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The term P (R(X, Y )) is the prior probability of R(X, Y ) observed from the
previous study. The term P (inf ormation/R(X, Y )) is likelihood of R(X, Y )
occurred in the previous study or data collected by the investigator. The sum
of the function

1
(P (Inf ormation))

should be equal to 1 as the theory of total Bayes

theorem. The relation between posterior and prior is
P osteriorP robability ∝ Likelihood × P riorP robability

(9)

The posterior density of R(X, Y ) is generated with
P (R(X, Y )/x, y) ∝ P (R(X, Y ))

(1 − R(X, Y )2 )(n−1)/2
3

(1 − R(X, Y ) ∗ r)n− 2

(10)

Let the mean and variance of X and Y are µ1 , µ2 , σ12 , σ22 respectively. The
mean(z) is derived from
ez =

µ1 σ22
µ2 σ12

(11)

The term R(X, Y ) is defined by tanhϵ and it is assumed ϵ ∼ N (z, n1 ). The
mathematical formulations are detailed in Fisher (1915). The hyperbolic transformation plays role to consider the conjugate prior with normal distributions.
The posterior mean can be represented with
µposterior = ϵ2posterior [ηprior tanh−1 R(x, y)prior +ηlikelihood tanh−1 R(x, y)likelihood ]
(12)
1
=
ηprior + ηlikelihood

(13)

P (R(X, Y )) ∝ (1 − R(X, Y )2 )c

(14)

2
σposterior

The prior with the form

The prior is dependent on the choice of c. The c = 0 gives the P (R(X, Y ) ∝ 1
The specification of prior is important for testing the parameters in hypothesis
H0 and H1 . The main focus of research in Bayesian approach is the specification
of prior. The prior specification is carried out through regression modeling. Let
the response of interest (Y ), covariates (X) ,error(ϵ) and intercept (α) are in
regression line through
Y = α + βX + ϵ

(15)

5
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Zellner (1986) has introduced the g prior for the above mentioned β coefficeint.
However, it is the extension of Jeffrey’s prior on the error precision ϕ with
uniform prior of interest α by
p(β|ϕ, g, X) = N (0,

g T −1
1
(X X) ), p(ϕ, α) ∝
ϕ
ϕ

(16)

The information about β can be obtained through ϕ−1 (X T X)−1 . Further, specified value of g gives the exposure about observed data. The specified value of
g = 1 says no influences of observed data. Whereas, g = 5 gives 15 weight as the
observed data. The selection of value of g is very important[10]. It is considered
as g = n. n is the sample size. discussed to consider g = k. (k is the number of
parameters). There are several literatures about selection of g prior. The work
is contributed with Jeffrey’s-Zellner-sion (JZS) prior for g-value. It was represented by Liang and his colleagues [11] and applied for correlation coefficient
[12]. The prior is like
∫

g
N (0, (X T X)−1 )p(g)dy
θ

p(β|ϕ, g, X) =

1
ϕ

(18)

n 12
n
− 23 − 2g
2)
1 g
Γ( 2 )

(19)

p(ϕ) ∝
p(g) =

(17)

The above mentioned formula is also useful to calculate Bayes factor. The prior
is applied as default prior for t-test [8]. The Bayesian factor is applied through
JZS for DC in regression line. The regression coefficient β is allowed to the
application JZS prior. Our goal is to compute DC, Intercept (α), regression
coefficient (β) and error term (ϵ) s detailed in equation(1). Let the equation (1)
further separated into Model (M1 ) and Model(M0 ) by

M1 : Y = α + βX + ϵ

(20)

M0 : Y = α + ϵ

(21)

The model ((M1 )) states the presence of DC and absence of it by Model ((M0 )).
Now, the Bayes Factor through JZS is defined [11] as,
6
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BF10 =

( n2 )1/2
×
Γ(1/2)

∫

∞

(1 + g)((n−2)/2 × [1 + (1 − r2 )g]−

(n−1)
2

g − 2 e−( 2g ) dg (22)
3

n

0

BF10 =

p(Y /M1 )
p(Y /M0 )

(23)

If the value of BF10 becomes more than 1, it state about presences of DC
otherwise not.

Testing
Under the null hypothesis H0 , the model (M0 ) is assumed and (M1 ) for
alternative one i.e H1 . The prior probability of null is assigned as p(M0 ) and
alternative as p(M1 ). Thereafter, Baye’s theorem is applied on the observed
data to compute posterior probability of the hypothesis. The appearance of
posterior probability of alternative Hypothesis is computed as
p(M1 |Y ) =

p(Y |M1 )p(M1 )
p(Y |M1 )p(M1 ) + p(Y |M0 )p(M0 )

(24)

The termP (Y |M1 )is the marginal likelihood of the data for alternative hypothesis. Further, the marginal likelihood is calculated as
∫ ∞
p(Y |M1 ) =
p(Y |θ, M1 )p(θ|H1 )dθ

(25)

θ

Bayes Factor ([13]) is useful to compute the appearance of P (M1 |Y ) in comparison to P (M0 |Y ):
p(M1 |Y )
p(M1 )
= BF10 ×
p(M0 |Y )
p(M0 )

(26)

Illustrated Example
The importance of Aminotransferases to detect malfunction of live, heart,
lungs, skeletal and brain [14]. The Aminotransferases can be separated into Alanine aminotransferase(ALT) and Aspartate aminotransferase(AST) [15]. Serum
ALT is useful to detect various liver disease[16]. Recently, AST and ALT is found
7
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as suitable marker for healthy Indian population for Liver Cirrhosis [17]. This
study is devoted to explore the DC between AST and ALT measurements of the
same individuals. The generated information between AST and ALT is used as
prior information of sample size of 4917 individuals[17]. The raw data on AST
and ALT of 606 individuals are detailed [18]. This work is devoted to illustrate
the DC between AST and ALT observations of 606 individuals. In both the
above mentioned study, the relation between Serum alanine aminotransferase
(ALT) and serum aminotransferase (AST) are observed. The relations between
variables are explored through distance covariance with Bayesian approach.The
first relation between ALT and AST is observed [17]. The measured distance
correlation data is observed with error. Bayesian posterior estimate is computed
for robust DC between ALT and AST by,

2
σposterior
=

1
1
=
= 0.00018
ηprior + ηlikelihood
4917 + 606

(27)

µP osterior = 0.00018(4917tanh−1 + 606tanh−1 0.80)

(28)

µposterior = 0.44

(29)

√
2
µposterior ± 1.96 (σpost
) = 0.44 ± 1.96(0.00018)1/2

(30)

The confidence interval is

i.e. (0.41, 0.46). It shows the posterior estimates of DC i.e R(X, Y ) is 0.44 with
credible interval (0.41, 0.46). This simple approach for DC can be extended in
other experimental research. The posterior computed mean is 0.44 and sample
size 606. The values are applied to obtain the BF10 in equation (23). The BF10
is calculated with 8.3. It is the evidence in favor of M1 in comparison to model
M0 . The presence of DC is tested through g prior.

Discussion
Recently, the testing process to check the presences of DC has been attempted. The t-test is found suitable to test the presence of DC. The relevant

8
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factors are proposed to perform it[3]. The evaluation of direct relation between
two variables is important. Pearson and Spearman correlations are commonly
applied tools to explore relation between variables. The strength of relation between variable can be classified by Cannonical, Rank and Renyi Correlation [4].
The widely explored correlation tool-Pearson correlation fails in multivariate
data set. It becomes zero for independent bivariate normal distribution. But
it failed to specify multivariate dependence in general. The limitation can be
overcome by joint independence of the random variable through DC. The DC
is product-moment correlation and generalized form of bivariate measures of
dependency. It is very much useful and unexplored area for statistical inference.
The idea of this work is to establish the application of new types of correlation
tools for measurement of dependence between variables. It is more applicable
for complicated multivariate data. The detailed application DC is recently established [2]. There are several advantages for application of DC over simple.
The Bayesian application on DC computation has been elaborated [7]. But, the
application of g-prior of DC testing is completely new. It is general tendency to
avoid the prior information about the relation between variable. The Bayesian
gives the scope to consider the prior information of the relation between variables
to explore the strength of current relation between variables.The application of
Bayesian to compute DC is illustrated and Hypothesis test statistics through
Bayes Factor is detailed on Biochemcal marker for liver performance. The work
is illustrated with the estimation of DC between AST and ALT.It is dedicated
for Bayesian test to compute DC. The work is not an attempt to develop a
new statistical model. But it is an effort to explore the application of Bayesian
approach to compute DC. The application is illustrated with biomarker of liver
cirrhosis observed through clinical trial data analysis. Bayesian can be useful to
get prominent evidence for test statistics on relation between variables. Bayes
factor is useful for computation of DC. It is useful to figure out the strength of
hypothesis. It can be considered as easily interpretable tool to discover the relations.This illustrated tool can be widely accepted for future research to explore
relation between variables.
9
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[15] F. Wróblewski, The clinical significance of transaminase activities of serum,
The American journal of medicine 27 (6) (1959) 911–923.
[16] D. Prati, E. Taioli, A. Zanella, E. Della Torre, S. Butelli, E. Del Vecchio,
L. Vianello, F. Zanuso, F. Mozzi, S. Milani, et al., Updated definitions of
healthy ranges for serum alanine aminotransferase levels, Annals of internal
medicine 137 (1) (2002) 1–10.
[17] S. Kumar, A. Amarapurkar, D. Amarapurkar, Serum aminotransferase levels in healthy population from western india, The Indian journal of medical
research 138 (6) (2013) 894.
11

Hosted by The Berkeley Electronic Press

[18] H. Southworth, J. E. Heffernan, Extreme value modelling of laboratory
safety data from clinical studies, Pharmaceutical statistics 11 (5) (2012)
361–366.

12

http://biostats.bepress.com/cobra/art113

